熱門資訊> 正文
Candel Therapeutics与Trinity Capital签署1.3亿美元定期贷款安排
2025-10-15 02:56
- Candel Therapeutics (NASDAQ:CADL) announced on Tuesday that it has entered into a five-year, $130M term loan facility with Trinity Capital.
- The facility included four tranches, starting with the first $50M available to draw at closing, followed by the second and third $50M, which were drawn subject to the achievement of certain regulatory, clinical, and operational milestones mentioned in the agreement, and the fourth tranche of $30 million is available at the lender’s discretion.
- The Company plans to use the first tranche, will refinance the prior loan agreement, and provide working capital. Subsequent tranches will be used to fund its general corporate purposes, completion of critical launch readiness, medical affairs and pre-commercialization activities, and potential commercial launch.
More on Candel Therapeutics
- Candel Therapeutics Has A Protracted, But Real, Timeline To Approval Now
- Candel Therapeutics: Potentially The Next Exciting Oncology Story
- Candel Therapeutics: Oncolytic Immunotherapy Showing Broad Efficacy In Tough Tumors
- Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts
- Seeking Alpha’s Quant Rating on Candel Therapeutics
推薦文章
美股機會日報 | 金價延續跌勢！黃金股盤前續跌，哈莫尼黃金大跌超6%；Beyond Meat盤前飆漲逾80%
AI仍是焦點！一圖看懂美股「七巨頭」Q3財報前瞻
貝萊德周度投資觀點：美國企業盈利韌性仍是關鍵
AI熱潮仍在湧動！小摩：英偉達(NVDA.US)、AMD(AMD.US)和博通(AVGO.US)營收上行潛力被低估
消息稱特朗普政府計劃對全球藥品定價展開新的調查
金價大跌是什麼信號？前FED顧問：系統性「流動性危機」已至，金融體系正崩潰！
華盛早報 | 黃金遭全面拋售！一夜暴跌超5%創十二年最大單日跌幅；Beyond Meat受散户追捧，股價三日漲近6倍
德州儀器第四季度業績展望不及預期，暗示半導體行業復甦緩慢，績后股價大跌8%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
